SPINOSAD
| Brand name | NATROBA |
|---|---|
| Active ingredient | SPINOSAD |
| Strength | 0.9% |
| Dosage form | SUSPENSION |
| Route | TOPICAL |
| Modality | Small molecule |
| FDA approval | January 2011 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9895388 | November 2033 | use U-3365 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.